Ascentage Pharma Group International (HKG:6855)
33.60
-1.18 (-3.39%)
Aug 20, 2026, 4:09 PM HKT
Ascentage Pharma Group International Employees
Ascentage Pharma Group International had 767 employees as of December 31, 2025. The number of employees increased by 200 or 35.27% compared to the previous year.
Employees
767
Change
200
Growth
35.27%
Revenue / Employee
967.28K HKD
Profits / Employee
-2.21M HKD
Market Cap
12.36B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 767 | 200 | 35.27% |
| Jun 30, 2025 | 605 | - | - |
| Dec 31, 2024 | 567 | -16 | -2.74% |
| Dec 31, 2023 | 583 | 3 | 0.52% |
| Dec 31, 2022 | 580 | -33 | -5.38% |
| Dec 31, 2021 | 613 | 180 | 41.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Everest Medicines | 812 |
| Suzhou Ribo Life Science | 407 |
| CARsgen Therapeutics Holdings | 355 |
| HBM Holdings | 272 |
| Duality Biotherapeutics | 231 |
| Ascletis Pharma | 202 |
Ascentage Pharma Group International News
- 7 hours ago - Ascentage Pharma Group International H1 Earnings Call Highlights - MarketBeat
- 10 hours ago - Ascentage Pharma Group International Earnings Call Transcript: H1 2026 - Transcripts
- 10 hours ago - Ascentage Pharma Group International Earnings release: H1 2026 - Filings
- 10 hours ago - Ascentage Pharma Group International Slides: H1 2026 - Filings
- 23 hours ago - Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates - GlobeNewsWire
- 7 days ago - Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit - GlobeNewsWire
- 15 days ago - CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026 - GlobeNewsWire
- 15 days ago - Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026 - GlobeNewsWire